These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 14754757)

  • 21. Regulation of vascular smooth muscle soluble guanylate cyclase activity, mRNA, and protein levels by cAMP-elevating agents.
    Papapetropoulos A; Marczin N; Mora G; Milici A; Murad F; Catravas JD
    Hypertension; 1995 Oct; 26(4):696-704. PubMed ID: 7558233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nerve growth factor decreases soluble guanylate cyclase in rat pheochromocytoma PC12 cells.
    Liu H; Force T; Bloch KD
    J Biol Chem; 1997 Feb; 272(9):6038-43. PubMed ID: 9038227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators.
    Mülsch A; Bauersachs J; Schäfer A; Stasch JP; Kast R; Busse R
    Br J Pharmacol; 1997 Feb; 120(4):681-9. PubMed ID: 9051308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation.
    Sayed N; Baskaran P; Ma X; van den Akker F; Beuve A
    Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12312-7. PubMed ID: 17636120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension.
    Schermuly RT; Stasch JP; Pullamsetti SS; Middendorff R; Müller D; Schlüter KD; Dingendorf A; Hackemack S; Kolosionek E; Kaulen C; Dumitrascu R; Weissmann N; Mittendorf J; Klepetko W; Seeger W; Ghofrani HA; Grimminger F
    Eur Respir J; 2008 Oct; 32(4):881-91. PubMed ID: 18550612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble guanylyl cyclase expression is reduced in LPS-induced lung injury.
    Glynos C; Kotanidou A; Orfanos SE; Zhou Z; Simoes DC; Magkou C; Roussos C; Papapetropoulos A
    Am J Physiol Regul Integr Comp Physiol; 2007 Apr; 292(4):R1448-55. PubMed ID: 17204594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prolonged exposure of chromaffin cells to nitric oxide down-regulates the activity of soluble guanylyl cyclase and corresponding mRNA and protein levels.
    Ferrero R; Torres M
    BMC Biochem; 2002 Sep; 3():26. PubMed ID: 12350235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Desensitization of the soluble guanylyl cyclase/cGMP pathway by lipopolysaccharide in rat isolated pulmonary artery but not aorta.
    El-Awady MS; Smirnov SV; Watson ML
    Br J Pharmacol; 2008 Dec; 155(8):1164-73. PubMed ID: 18806822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nitric oxide-independent down-regulation of soluble guanylyl cyclase by bacterial endotoxin in astroglial cells.
    Baltrons MA; García A
    J Neurochem; 1999 Nov; 73(5):2149-57. PubMed ID: 10537075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic hypoxic decreases in soluble guanylate cyclase protein and enzyme activity are age dependent in fetal and adult ovine carotid arteries.
    Williams JM; White CR; Chang MM; Injeti ER; Zhang L; Pearce WJ
    J Appl Physiol (1985); 2006 Jun; 100(6):1857-66. PubMed ID: 16469937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soluble guanylate cyclase alpha(1) and beta(1) gene transfer increases NO responsiveness and reduces neointima formation after balloon injury in rats via antiproliferative and antimigratory effects.
    Sinnaeve P; Chiche JD; Nong Z; Varenne O; Van Pelt N; Gillijns H; Collen D; Bloch KD; Janssens S
    Circ Res; 2001 Jan; 88(1):103-9. PubMed ID: 11139481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. cGMP accumulation and gene expression of soluble guanylate cyclase in human vascular tissue.
    Papapetropoulos A; Cziraki A; Rubin JW; Stone CD; Catravas JD
    J Cell Physiol; 1996 May; 167(2):213-21. PubMed ID: 8613461
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developmental changes of nitric oxide-sensitive guanylyl cyclase expression in pulmonary arteries.
    Behrends S; Kempfert J; Mietens A; Koglin M; Scholz H; Middendorff R
    Biochem Biophys Res Commun; 2001 May; 283(4):883-7. PubMed ID: 11350067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Smooth muscle cell CYB5R3 preserves cardiac and vascular function under chronic hypoxic stress.
    Durgin BG; Wood KC; Hahn SA; McMahon B; Baust JJ; Straub AC
    J Mol Cell Cardiol; 2022 Jan; 162():72-80. PubMed ID: 34536439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 17 beta-estradiol modifies nitric oxide-sensitive guanylyl cyclase expression and down-regulates its activity in rat anterior pituitary gland.
    Cabilla JP; Díaz Mdel C; Machiavelli LI; Poliandri AH; Quinteros FA; Lasaga M; Duvilanski BH
    Endocrinology; 2006 Sep; 147(9):4311-8. PubMed ID: 16740976
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The beta2 subunit inhibits stimulation of the alpha1/beta1 form of soluble guanylyl cyclase by nitric oxide. Potential relevance to regulation of blood pressure.
    Gupta G; Azam M; Yang L; Danziger RS
    J Clin Invest; 1997 Sep; 100(6):1488-92. PubMed ID: 9294115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhaled nitric oxide decreases pulmonary soluble guanylate cyclase protein levels in 1-month-old lambs.
    Thelitz S; Bekker JM; Ovadia B; Stuart RB; Johengen MJ; Black SM; Fineman JR
    J Thorac Cardiovasc Surg; 2004 May; 127(5):1285-92. PubMed ID: 15115984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of proinflammatory tumor necrosis factor-{alpha}-induced inducible nitric-oxide synthase by xanthine-based 7-[2-[4-(2-chlorobenzene)piperazinyl]ethyl]-1,3-dimethylxanthine (KMUP-1) and 7-[2-[4-(4-nitrobenzene)piperazinyl]ethyl]-1, 3-dimethylxanthine (KMUP-3) in rat trachea: The involvement of soluble guanylate cyclase and protein kinase G.
    Wu BN; Chen CW; Liou SF; Yeh JL; Chung HH; Chen IJ
    Mol Pharmacol; 2006 Sep; 70(3):977-85. PubMed ID: 16754782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transdifferentiation of pulmonary arteriolar endothelial cells into smooth muscle-like cells regulated by myocardin involved in hypoxia-induced pulmonary vascular remodelling.
    Zhu P; Huang L; Ge X; Yan F; Wu R; Ao Q
    Int J Exp Pathol; 2006 Dec; 87(6):463-74. PubMed ID: 17222214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of endothelial nitric oxide in pulmonary and systemic arteries during hypoxia.
    Nuñez C; Victor VM; Martí M; D'Ocon P
    Nitric Oxide; 2014 Feb; 37():17-27. PubMed ID: 24365975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.